Need for care and life satisfaction in adult substance use disorder patients with and without attention deficit hyperactivity disorder (ADHD) or autism spectrum disorder (ASD)

Perspectives in Psychiatric Care

Volumn 51, Issue 1, 2015, Pages 4-15

  Kronenberg, Linda M ^a   Goossens, Peter J J ^b,c,d,e   van Etten, Derk M ^f   van Achterberg, Theo ^e   van den Brink, Wim ^g  

^a Advanced Nurse Practitioner Dual Diagnosis Department Dimence   (Netherlands)

^b SAXION UNIVERSITY OF APPLIED SCIENCES   (Netherlands)

^c Centre of Health SocialWork and Technology   (Netherlands)

^d Dimence   (Netherlands)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^f Victas Center for Addiction Care   (Netherlands)

^g AMSTERDAM INSTITUTE FOR ADDICTION RESEARCH   (Netherlands)

Author keywords

Attention deficit hyperactivity disorder; Autism spectrum disorder; Care need; Quality of life; Substance use disorder

Indexed keywords

ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; AUTISM SPECTRUM DISORDER; COMORBIDITY; FEMALE; HEALTH SERVICE; HUMAN; MALE; MIDDLE AGED; NEEDS ASSESSMENT; PSYCHIATRIC DIAGNOSIS; SATISFACTION; SUBSTANCE-RELATED DISORDERS;

ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; AUTISM SPECTRUM DISORDER; COMORBIDITY; DIAGNOSIS, DUAL (PSYCHIATRY); FEMALE; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; MALE; MIDDLE AGED; NEEDS ASSESSMENT; PERSONAL SATISFACTION; SUBSTANCE-RELATED DISORDERS;

EID: 84920935876     PISSN: 00315990     EISSN: 17446163     Source Type: Journal    
DOI: 10.1111/ppc.12056     Document Type: Article

References (68)

1. American Nurses Association. (2012). At 11-18-2012. Retrieved from http://www.nursingworld.org/EspeciallyForYou/What-is-Nursing
2. Biederman, J., Petty, C. R., Wilens, T. E., Fraire, M. G., Purcell, C. A., Mick, E., Faraone, S. V. (2008). Familial risk analyses of attention deficit hyperactivity disorder and substance use disorders. American Journal of Psychiatry, 165, 107-115. doi:10.1176/appi.ajp.2007.07030419
3. Biederman, J., Petty, C. R., Woodworth, K. Y., Lomedico, A., Hyder, L. L., & Faraone, S. V. (2012). Adult outcome of attention-deficit/hyperactivity disorder: A controlled 16-year follow-up study. Journal of Clinical Psychiatry, 71, 941-950. doi:10.4088/JCP.11m07529
4. Biederman, J., Wilens, T. E., Mick, E., Faraone, S. V., & Spencer, T. (1998). Does attention-deficit hyperactivity disorder impact the developmental course of drug and alcohol abuse and dependence? Biological Psychiatry, 44, 269-273. doi:10.1016/S0006-3223(97)00406-X
5. Björkman, T., & Svensson, B. (2005). Quality of life in people with severe mental illness. Reliability and validity of the Manchester Short Assessment of Quality of Life (MANSA). Nordic Journal of Psychiatry, 59(4), 302-306. doi:10.1080/08039480500213733
6. van Busschbach, J., & Wiersma, D. (1999). Behoefte, zorg en rehabilitatie in de chronische psychiatrie, een epidemiologisch studie. Groningen: Rijksuniversiteit Groningen.
7. Carey, M. P., Carey, K. B., & Meisler, A. W. (1991). Psychiatric symptoms in mentally ill chemical abusers. Journal of Nervous and Mental Disease, 179(3), 136-138.
8. Caton, C. L. M., Shrout, P. E., Eagle, P. F., Opler, L. A., Felix, A., & Dominguez, B. (1994). Risk factors for homelessness among schizophrenic men: A case-control study. American Journal of Public Health, 84, 265-270.
9. Chan, Y., Dennis, M. L., & Funk, R. R. (2008). Prevalence and comorbidity of major internalizing and externalizing problems among adolescents and adults presenting to substance abuse treatment. Journal of Substance Abuse Treatment, 34, 14-24. doi:10.1016/j.jsat.2006.12.031
10. nd ed.). Hillsdale, NJ: Lawrence Erlbaum Associates.
11. Costello, E. J., Erkanli, A., Federman, E., & Angold, A. (1999). Development of psychiatric comorbidity with substance abuse in adolescents: Effects of timing and sex. Journal of Clinical Child Psychology, 28, 298-311. doi:10.1207/S15374424jccp280302
12. Dixon, L., McNary, S., & Lehman, A. (1995). Substance abuse and family relationships of persons with severe mental illness. American Journal of Psychiatry, 152, 456-458.
13. Dopheide, J. A., & Pliszka, S. R. (2009). Attention-deficit-hyperactivity disorder: An update. Pharmacotherapy, 29(6), 656-679. doi:10.1592/phco.29.6.656
14. Drake, R. E., Essock, S. M., Shaner, A., Carey, K. B., Minkoff, K., Kola, L., Rickards, L. (2001). Implementing dual diagnosis services for clients with severe mental illness. Psychiatric Services, 52(4), 469-476. doi:10.1176/appi.ps.52.4.469
15. Drake, R. E., Osher, F. C., & Wallach, M. A. (1991). Homelessness and dual diagnosis. American Psychologist, 46, 1149-1158. doi:10.1037/0003-066X.46.11.1149
16. Drake, R. E., & Wallach, M. A. (1989). Substance abuse among the chronically mentally ill. Hospital and Community Psychiatry, 40(10), 1041-1046.
17. Drake, R. E., Wallach, M. A., Alverson, H. S., & Mueser, K. T. (2002). Psychosocial aspects of substance abuse by clients with severe mental illness. Journal of Nervous and Mental Disease, 190, 100-106.
18. Edward, K., & Robins, A. (2012). Dual diagnosis, as described by those who experience the disorder: Using the Internet as a source of data. International Journal of Mental Health Nursing, 21, 550-559. doi:10.1111/j.1447-0349.2012.00833.x
19. Effertz, T., & Mann, K. (2013). The burden and cost of disorders of the brain in Europe with the inclusion of harmful alcohol use and nicotine addiction. European Neuropsychopharmacology, 23(7), 742-748. doi:10.1016/j.euroneuro.2012.07.010
20. van Emmerik-van Oortmerssen, K., van de Glind, G., van den Brink, B., Smit, F., Crunelle, C. L., Swetsa, M., & Schoevers, R. A. (2012). Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: A meta-analysis and meta-regression analysis. Drug and Alcohol Dependence, 122, 11-19. doi:10.1016/j.drugalcdep.2011.12.007
21. Fazzone, P. A., Holton, J. K., & Reed, B. G. (1997). Substance abuse treatment and domestic violence: Treatment Improvement Protocol (TIP) Series 25. Rockville, U.S. Department of Health and Human Services; Public Health Service; Substance Abuse and Mental Health Services Administration; Center for Substance Abuse Treatment.
22. Finkelstein, N. B. (Chair), & Mora, J. (Co-Chair) (2009). Substance abuse treatment: Addressing the specific needs of women: Treatment Improvement Protocol (TIP) Series 51. Rockville, U.S. Department of Health and Human Services; Public Health Service; Substance Abuse and Mental Health Services Administration; Center for Substance Abuse Treatment.
23. Fombonne, E. (2009). Epidemiology of pervasive developmental disorders. Pediatric Research, 65(6), 591-598. doi:10.1203/PDR.0b013e31819e7203
24. Forray, A., & Sofuoglu, M. (2012. Future pharmacological treatments for substance use disorders. British Journal of Clinical Pharmacology. doi:10.1111/j.1365-2125.2012.04474.x
25. Hahesy, A. L., Wilens, T. E., Biederman, J., Van Patten, S. L., & Spencer, T. (2002). Temporal association between childhood psychopathology and substance use disorders: Findings from a sample of adults with opioid or alcohol dependency. Psychiatry Research, 109, 245-253. doi:10.1016/S0165-1781(02)00015-X
26. Hasina, D., & Kilcoyne, B. (2012). Comorbidity of psychiatric and substance use disorders in the United States: Current issues and findings from the NESARC. Current Opinion in Psychiatry, 25, 165-171. doi:10.1097/YCO.0b013e3283523dcc
27. Hawthorne, W. B., Folsom, D. P., Sommerfeld, D. H., Lanouette, N. M., Lewis, M., Aarons, G. A., Jeste, D. V. (2012). Incarceration among adults who are in the public mental health system: Rates, risk factors, and short-term outcomes. Psychiatric Services, 63(1), 26-32. doi:10.1176/appi.ps.201000505
28. Jacobi, F., Wittchen, H. U., Hölting, C., Höfler, M., Pfister, H., Müller, N., & Lieb, R. (2004). Prevalence, comorbidity and correlates of mental disorders in the general population: Results from the German Health Interview and Examination Survey (GHS). Psychological Medicine, 34, 597-611. doi:10.1017/S0033291703001399
29. de Jong, C. A. J., Willems, J. C. E. W., Schippers, G. M., & Hendriks, V. M. (1995). The Addiction Severity Index-Reliability and validity in a Dutch alcohol population. International Journal of the Addictions, 30, 605-616. doi:10.3109/10826089509048747
30. Kelly, T. M., Daley, D. C., & Douaihy, A. B. (2012). Treatment of substance abusing patients with comorbid psychiatric disorders. Addictive Behaviors, 37, 11-24. doi:10.1016/j.addbeh.2011.09.010
31. Kessler, R. C., Adler, L., Barkley, R., Biederman, J., Conners, C. K., Demler, O., Zaslavsky, A. M. (2006). The prevalence and correlates of adult ADHD in the United States: Results from the National Comorbidity Survey. American Journal of Psychiatry, 163, 716-723. doi:10.1176/appi.ajp.163.4.716
32. Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005). Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication. Archives of General Psychiatry, 62, 593-602. doi:10.1001/archpsyc.62.6.593
33. Kokkevi, A., & Hartgers, C. (1995). EuropASI: European adaptation of a multidimensional assessment instrument for drug and alcohol dependence. European Addiction Research, 1, 208-210. doi:10.1159/000259089
34. Kooij, J. J. S., & Francken, M. H. (2007). Diagnostisch Interview voor ADHD bij volwassenen (DIVA) versie augustus 2007. Kenniscentrum ADHD bij volwassenen, PsyQ.
35. Kooij, S., van de Glind, G., Van Duin, D., Goossensen, A., & Carpentier, P. (2004). Protocol ADHD bij Verslaving: Screening, diagnostiek en behandeling voor de ambulante en klinische Verslavingszorg. Utrecht: Trimbos-instituut.
36. Lord, C., Rutter, M., & Le Couteur, A. (1994). Autism diagnostic interview-revised: A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. Journal of Autism and Developmental Disorders, 24, 659-685. doi:10.1007/BF02172145
37. McNiel, D. E., Binder, R. L., & Robinson, J. C. (2005). Incarceration associated with homelessness, mental disorder, and co-occurring substance abuse. Psychiatric Services, 56(7), 840-846. doi:10.1176/appi.ps.56.7.840
38. Murthy, P., & Chand, P. (2012). Treatment of dual diagnosis disorders. Current Opinion in Psychiatry, 25, 194-200. doi:10.1097/YCO.0b013e328351a3e0
39. Nicholas, J. S., Charles, J. M., Carpenter, L. A., King, L. B., Jenner, W., & Spratt, E. G. (2008). Prevalence and characteristics of children with autism-spectrum disorders. Annals of Epidemiology, 18(2), 130-136. doi:10.1016/j.annepidem.2007.10.013
40. Phelan, M., Slade, M., Thornicroft, G., Dunn, G., Holloway, F., Wykes, T., Hayward, P. (1995). The Camberwell Assessment of Need: The validity and reliability of an instrument to assess the needs of people with severe mental illness. British Journal of Psychiatry, 167(5), 589-595. doi:10.1192/bjp.167.5.589
41. Polanczyk, G., Silva de Lima, M., Horta, B. L., Biederman, J., & Rohde, L. A. (2007). The worldwide prevalence of ADHD: A systematic review and metaregression analysis. American Journal of Psychiatry, 164(6), 942-948.
42. Priebe, S., Huxley, P., Knight, S., & Evans, S. (1999). Application and results of the Manchester Short Assessment of Quality of Life (MANSA). International Journal of Social Psychiatry, 45(1), 7-12. doi:10.1177/002076409904500102
43. Regier, D. A., Farmer, M. E., Rae, D. S., Locke, B. Z., Keith, S. J., Judd, L. L., & Goodwin, F. K. (1990). Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. Journal of the American Medical Association, 264, 2511-2518. doi:10.1001/jama.1990.03450190043026
44. Renty, L., & Roeyers, H. (2006). Quality of life in high-functioning adults with autism spectrum disorder. The predictive value of disability and support characteristics. Autism, 10(5), 511-524. doi:10.1177/1362361306066604
45. Reynolds, T., Thornicroft, G., Abas, M., Woods, B., Hoe, J., Leese, M., & Orrell, M. (2000). Camberwell Assessment of Need for the Elderly (CANE). Development, validity and reliability. British Journal of Psychiatry, 176, 444-452. doi:10.1192/bjp.176.5.444
46. Rimland, B. (1968). On the objective diagnosis of infantile autism. Acta Paedopsychiatrica, 35, 146-161.
47. Rosenberg, S. D., Goodman, L. A., Osher, F. C., Swartz, M. S., Essock, S. M., Butterfield, M. I., Salyers, M. P. (2001). Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness. American Journal of Public Health, 91(1), 31-37.
48. Sacks, S. (Consensus Panel Chair), & Ries, R. K. (Consensus Panel Co-Chair) (2005). Substance abuse treatment for persons with co-occurring disorders: Treatment Improvement Protocol (TIP) Series 42. Rockville, U.S. Department of Health and Human Services; Public Health Service; Substance Abuse and Mental Health Services Administration; Center for Substance Abuse Treatment.
49. Saitz, R., Larson, M. J., LaBelle, C., Richardson, J., & Samet, J. H. (2008). The case for chronic disease management for addiction. Journal of Addiction Medicine, 2(2), 55-65. doi:10.1097/ADM.0b013e318166af74
50. Santosh, P. J., & Mijovic, A. (2006). Does pervasive developmental disorder protect children and adolescents against drug and alcohol use? European Child & Adolescent Psychiatry, 15(4), 183-188. doi:10.1007/s00787-005-0517-0
51. Scheurich, A., Muller, M. J., Wetzel, H., Anghelescum, I., Klawe, C., Ruppe, A., Szegedi, A. (2000). Reliability and validity of the German version of the European Addiction Severity Index (EuropASI). Journal of Studies on Alcohol, 61(6), 916-919.
52. Scott, C. K., Dennis, M. L., Laudet, A., Funk, R. R., & Simeone, R. S. (2011). Surviving drug addiction: The effect of treatment and abstinence on mortality. American Journal of Public Health, 101(4), 737-744. doi:10.2105/AJPH.2010.197038
53. Seltzer, M. M., Krauss, M., Shattuck, P. T., Orsmond, G., Swe, A., & Lord, C. (2003). The symptoms of autism spectrum disorders in adolescence and adulthood. Journal of Autism and Developmental Disorders, 33, 565-581.
54. Sheehan, D. V., Lecrubier, Y., Sheehan, K. H., Amorim, P., Janavs, J., Weiller, E., Dunbar, G. C. (1998). The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry, 59, 22-33.
55. Simonoff, E., Pickles, A., Charman, T., Chandler, S., Loucas, T., & Baird, G. (2008). Psychiatric disorders in children with autism spectrum disorders: Prevalence, comorbidity, and associated factors in a population derived sample. Journal of the American Academy of Child and Adolescent Psychiatry, 47(8), 921-929. doi:10.1097/CHI.0b013e318179964f
56. Singh, S. K. B., Hellemans, H., & Dom, G. (2012). Autism spectrum disorder and substance use disorder: An unknown comorbidity? (Article in Dutch: Autismespectrumstoornis en verslaving: Een onbekende comorbiditeit?) Tijdschrift Voor Psychiatrie, 54(10), 893-897.
57. Sizoo, B., van den Brink, W., van Gorissen Eenigee, M., & van den Gaag, R. J. (2009). Personality characteristics of adults with autism spectrum disorders or attention deficit hyperactivity disorder with and without substance use disorders. Journal of Nervous and Mental Disease, 197(6), 450-454. doi:10.1097/NMD.0b013e3181a61dd0
58. Sizoo, B., van den Brink, W., Koeter, M., van den Gorissen Eenigee, M., van Wijngaarden-Cremers, P., & van den Gaag, R. J. (2010). Treatment seeking adults with autism or ADHD and co-morbid substance use disorder: Prevalence, risk factors and functional disability. Drug and Alcohol Dependence, 107, 44-50. doi:10.1016/j.drugalcdep.2009.09.003
59. Swofford, C., Kasckow, J., & Scheller-Gilkey, G. (1996). Substance use: A powerful predictor of relapse in schizophrenia. Schizophrenia Research, 20, 145-151. doi:10.1016/0920-9964(95)00068-2
60. Toussaint, C. (red). (2009). Diagnostiek voor volwassenen met (vermoeden van) autisme spectrum stoornissen. Intersectorale werkgroep diagnostiek volwassenen met ASS, Samenwerkingsverband Autisme Overijssel.
61. Vegt, R., Bertoli-Avella, A. M., Tulen, J. H., de Graaf, B., Verkerk, A. J., Vervoort, J., Oostra, B. A. (2010). Genome-wide linkage analysis in a Dutch multigenerational family with attention deficit hyperactivity disorder. European Journal of Human Genetics, 18, 206-211. doi:10.1038/ejhg.2009.148
62. Watkins, K. E., Hunter, S. B., Wenzel, S. L., Tu, W., Paddock, S. M., Griffin, A., & Ebener, P. (2004). Prevalence and characteristics of clients with co-occurring disorders in outpatient substance abuse treatment. American Journal of Drug and Alcohol Abuse, 30(4), 749-764. doi:10.1081/ADA-200037538
63. Wilens, T. E. (1998). AOD use and attention deficit/hyperactivity disorder. Alcohol Health & Research World, 22, 127-130.
64. Wilens, T. E. (2004a). Attention-deficit/hyperactivity disorder and the substance use disorders: The nature of the relationship, subtypes at risk, and treatment issues. Psychiatric Clinics of North America, 27, 283-301. doi:10.1016/S0193-953X(03)00113-8
65. Wilens, T. E. (2004b). Impact of ADHD and its treatment on substance abuse in adults. Journal of Clinical Psychiatry, 65(3), 38-45.
66. Wilens, T. E., & Morrison, N. R. (2011). The intersection of attention-deficit/hyperactivity disorder and substance abuse. Current Opinion in Psychiatry, 24, 280-285. doi:10.1097/YCO.0b013e328345c956
67. Wing, L., Leekam, S. R., Libby, S. J., Gould, J., & Larcombe, M. (2002). The diagnostic interview for social and communication disorders: Background, interrater reliability and clinical use. Journal of Child Psychology and Psychiatry, 43, 307-325. doi:10.1111/1469-7610.00023
68. Wittchen, H. U., Jacobi, F., Rehm, J., Gustavsson, A., Svensson, M., Jönsson, B., Steinhausen, H.-C. (2011). The size and burden of mental disorders and other disorders of the brain in Europe 2010. European Neuropsychopharmacology, 21, 655-679. doi:10.1016/j.euroneuro.2011.07.018